Krystal Biotech CEO sells 25K shares in plan
Rhea-AI Filing Summary
Krystal Biotech, Inc. (KRYS) reports that President and CEO, director, and more-than-10% owner Krishnan Krish S sold 25,000 shares of common stock on September 4, 2026 in multiple open-market transactions around the mid-$350s per share, under a Rule 10b5-1 trading plan adopted September 4, 2025 that has now reached its maximum and terminated. He continues to hold shares indirectly through family trusts, including 90,000, 77,710, and 50,000 shares, respectively.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 25,000 shares
Net Sell
16 txns
Insider
Krishnan Krish S
Role
President and CEO
Sold
25,000 shs ($8.98M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2, F3 | 520 | $354.54 | $184K |
| Sale | Common Stock F4 | 2,029 | $355.5719 | $721K |
| Sale | Common Stock F5 | 3,297 | $356.3687 | $1.17M |
| Sale | Common Stock F6 | 3,981 | $357.5738 | $1.42M |
| Sale | Common Stock F7 | 3,143 | $358.4182 | $1.13M |
| Sale | Common Stock F8 | 3,357 | $359.3861 | $1.21M |
| Sale | Common Stock F9 | 2,266 | $360.463 | $817K |
| Sale | Common Stock F10 | 1,214 | $361.6091 | $439K |
| Sale | Common Stock F11 | 2,010 | $362.6504 | $729K |
| Sale | Common Stock F12 | 573 | $363.3424 | $208K |
| Sale | Common Stock F13 | 1,358 | $364.4794 | $495K |
| Sale | Common Stock F14 | 847 | $365.4163 | $310K |
| Sale | Common Stock F15 | 405 | $366.5567 | $148K |
| holding | Common Stock F16 | -- | -- | -- |
| holding | Common Stock F17 | -- | -- | -- |
| holding | Common Stock F18 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,347,543 shares (Direct);
Common Stock — 90,000 shares (Indirect, By SMK Trust FBO KSK);
Common Stock — 77,710 shares (Indirect, By Krish Srinivas Krishnan Trust);
Common Stock — 50,000 shares (Indirect, By Krishnan Family Trust)
Footnotes (18)
- F1. The Reporting Person may be deemed to beneficially own shares of the Issuer's common stock directly owned by the Reporting Person's spouse, Suma M. Krishnan. Such shares and transactions by the Reporting Person's spouse are not included in this Form 4, as they are being reported separately on a Form 4 filed by his spouse. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F2. The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025. The Rule 10b5-1 trading plan has reached the maximum number of shares to be sold under such plan and has terminated.
- F3. The transaction was executed in multiple trades ranging from $353.98 to $354.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F4. The transaction was executed in multiple trades ranging from $354.98 to $355.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F5. The transaction was executed in multiple trades ranging from $355.98 to $356.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F6. The transaction was executed in multiple trades ranging from $356.99 to $357.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F7. The transaction was executed in multiple trades ranging from $357.99 to $358.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F8. The transaction was executed in multiple trades ranging from $358.99 to $359.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F9. The transaction was executed in multiple trades ranging from $360.01 to $361.005. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F10. The transaction was executed in multiple trades ranging from $361.02 to $362.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F11. The transaction was executed in multiple trades ranging from $362.02 to $363.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F12. The transaction was executed in multiple trades ranging from $363.05 to $364.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F13. The transaction was executed in multiple trades ranging from $364.07 to $365.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F14. The transaction was executed in multiple trades ranging from $365.07 to $366.03. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F15. The transaction was executed in multiple trades ranging from $366.39 to $366.91. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F16. Held by SMK Trust FBO KSK, an irrevocable trust established by Mrs. Krishnan for the benefit of Mr. Krishnan who serves as a co-trustee and shares voting and investment power with a 3rd party co-trustee.
- F17. Held by the Krish Srinivas Krishnan Trust dated July 7, 2026. The Reporting Person is the grantor and trustee of the trust, has the power to revoke the trust, and has voting and investment power with respect to the shares held by the trust.
- F18. Held by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.
Key Figures
Shares sold: 25,000 shares
Sale price example: $354.54 per share
Highest trade range price: $366.91 per share
+5 more
8 metrics
Shares sold
25,000 shares
Total common shares sold by Krishnan Krish S on September 4, 2026
Sale price example
$354.54 per share
One reported weighted average sale price tranche on September 4, 2026
Highest trade range price
$366.91 per share
Upper end of the disclosed intraday price range in footnote F15
Lowest trade range price
$353.98 per share
Lower end of the disclosed intraday price range in footnote F3
SMK Trust FBO KSK holdings
90,000 shares
Indirect KRYS common stock held through SMK Trust FBO KSK
Krish Srinivas Krishnan Trust holdings
77,710 shares
Indirect KRYS common stock held through Krish Srinivas Krishnan Trust
Krishnan Family Trust holdings
50,000 shares
Indirect KRYS common stock held through Krishnan Family Trust
Rule 10b5-1 plan adoption date
September 4, 2025
Date the CEO’s trading plan for these sales was adopted
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, beneficial ownership, pecuniary interest, +2 more
6 terms
Rule 10b5-1 trading plan regulatory
"The sales reported were pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported above reflects the weighted average sale price"
beneficial ownership financial
"The Reporting Person may be deemed to beneficially own shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of such shares except to the extent of his pecuniary interest"
irrevocable trust financial
"an irrevocable trust established by Mrs. Krishnan for the benefit of Mr. Krishnan"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
voting and investment power financial
"shares voting and investment power with a 3rd party co-trustee"
FAQ
What insider transaction did KRYS disclose for Krishnan Krish S?
Krystal Biotech disclosed that President and CEO Krishnan Krish S sold 25,000 shares of KRYS common stock on September 4, 2026 in a series of open-market transactions, as reported on a Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
